Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Teva pharmaceutical industries ltd    crawled time : 13:20    save search

Alvotech to Report Financial Results for the First Half of 2023 on August 30, 2023, and Host Business Update Conference Call on August 31, 2023, at 8:00 am ET
Published: 2023-08-22 (Crawled : 13:20) - globenewswire.com
ALVO | $13.39 0.45% 0.45% 200K twitter stocktwits trandingview |
n/a
| | O: -0.21% H: 4.22% C: 0.93%
KMDA | $5.1 -0.99% 5.3K twitter stocktwits trandingview |
Health Technology
| | O: -1.43% H: 0.0% C: -0.73%

conference report business update financial results
Teva Launches New “Pivot to Growth” Strategy
Published: 2023-05-18 (Crawled : 13:20) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M twitter stocktwits trandingview |
Health Technology
| | O: 3.94% H: 3.67% C: -2.25%

teva
Teva’s Ambitious Climate Targets Externally Validated by the Science Based Targets initiative (SBTi)
Published: 2023-01-19 (Crawled : 13:20) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M twitter stocktwits trandingview |
Health Technology
| | O: -3.04% H: 1.43% C: 0.38%


Respiratory Inhalers Market Report 2023-2033
Published: 2023-01-03 (Crawled : 13:20) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.42% H: 1.35% C: 1.22%
PHG | News | $21.01 1.94% 0.0% 2M twitter stocktwits trandingview |
Health Technology
| | O: 3.6% H: 1.03% C: 0.71%
ATR | $140.15 -0.12% 0.0% 420K twitter stocktwits trandingview |
Process Industries
| | O: 0.55% H: 0.44% C: -0.29%

report respiratory market
Outlook on the Non-steroidal Anti-inflammatory Drugs Global Market to 2028 - Featuring Pfizer, GlaxoSmithKline, Bayer and Teva Pharmaceutical Industries Among Others
Published: 2022-09-26 (Crawled : 13:20) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630 twitter stocktwits trandingview |
Health Technology
| | O: 4.62% H: 0.0% C: -4.87%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: 5.77% H: 0.0% C: -2.27%
AZNCF | News | $138.73 -4.19% 3.7K twitter stocktwits trandingview |
Health Technology
| | O: -1.15% H: 0.0% C: -2.43%
PFE | News 4 | $26.32 0.23% 0.0% 24M twitter stocktwits trandingview |
Health Technology
| | O: -0.61% H: 1.19% C: 0.05%
GSK | News | $41.24 1.6% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 0.72% C: -0.83%
LLY | News | $745.69 1.96% -0.16% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.85% H: 0.95% C: -0.42%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.29% H: 0.35% C: -0.67%
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.52% H: 0.48% C: -1.36%

global teva market
Aflibercept 8 mg Meets Primary Endpoints in Two Global Pivotal Trials for DME and wAMD, with a Vast Majority of Patients Maintained on 12- and 16-week Dosing Intervals
Published: 2022-09-08 (Crawled : 13:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 0.0% C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K twitter stocktwits trandingview |
Health Technology
| | O: 15.18% H: 4.65% C: 3.18%

trials global
Regeneron Completes Acquisition of Checkmate Pharmaceuticals
Published: 2022-05-31 (Crawled : 13:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -2.5% H: 0.54% C: 0.54%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -3.21% H: 0.0% C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K twitter stocktwits trandingview |
Health Technology
| | O: 1.6% H: 0.0% C: -4.05%

acquisition
Growth: Global Biosimilar Market to Generate $83,836.4 Million and Exhibit a CAGR of 24.9% from 2021 to 2028 [170-Pages] | Report by Research Dive
Published: 2022-05-30 (Crawled : 13:20) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

research biosimilar report market
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.